Roy P, Islam J, Lalhlenmawia H
Egypt Heart J. 2023; 75(1):24.
PMID: 37014444
PMC: 10073393.
DOI: 10.1186/s43044-023-00352-7.
Donath M, Dinarello C, Mandrup-Poulsen T
Nat Rev Immunol. 2019; 19(12):734-746.
PMID: 31501536
DOI: 10.1038/s41577-019-0213-9.
Shuwa H, Dallatu M, Yeldu M, Ahmed H, Nasir I
Malays J Med Sci. 2019; 25(4):51-62.
PMID: 30914847
PMC: 6422540.
DOI: 10.21315/mjms2018.25.4.5.
Kurauti M, Costa-Junior J, Ferreira S, Santos G, Sponton C, Carneiro E
Sci Rep. 2017; 7:46750.
PMID: 28429777
PMC: 5399448.
DOI: 10.1038/srep46750.
Khan M, Khan M, Kashiwagi S, Kem W, Yasuhara S, Kaneki M
Shock. 2017; 48(2):227-235.
PMID: 28282360
PMC: 5511057.
DOI: 10.1097/SHK.0000000000000849.
Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice.
Stuart W, Brown N, Paluch A, Waltz S
Am J Physiol Endocrinol Metab. 2015; 308(7):E562-72.
PMID: 25648832
PMC: 4385874.
DOI: 10.1152/ajpendo.00467.2014.
Targeting inflammation in the treatment of type 2 diabetes: time to start.
Donath M
Nat Rev Drug Discov. 2014; 13(6):465-76.
PMID: 24854413
DOI: 10.1038/nrd4275.
Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice.
Fisette A, Poursharifi P, Oikonomopoulou K, Munkonda M, Lapointe M, Cianflone K
Mediators Inflamm. 2013; 2013:713284.
PMID: 23737652
PMC: 3666230.
DOI: 10.1155/2013/713284.
Role of cardiotrophin-1 in obesity and insulin resistance.
Moreno-Aliaga M, Romero-Lozano M, Castano D, Prieto J, Bustos M
Adipocyte. 2013; 1(2):112-115.
PMID: 23700521
PMC: 3609088.
DOI: 10.4161/adip.19696.
Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial.
Viana E, Araujo-Dasilio K, Miguel G, Bressan J, Lemos E, Moyses M
Obes Surg. 2013; 23(8):1252-61.
PMID: 23475776
DOI: 10.1007/s11695-013-0894-2.
Periodontitis and insulin resistance: casual or causal relationship?.
Gurav A
Diabetes Metab J. 2013; 36(6):404-11.
PMID: 23275933
PMC: 3530710.
DOI: 10.4093/dmj.2012.36.6.404.
Modulation of hsa-miR-26b levels following adipokine stimulation.
Xu G, Ji C, Shi C, Fu H, Zhu L, Zhu L
Mol Biol Rep. 2013; 40(5):3577-82.
PMID: 23275201
DOI: 10.1007/s11033-012-2431-0.
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.
Ellingsgaard H, Hauselmann I, Schuler B, Habib A, Baggio L, Meier D
Nat Med. 2011; 17(11):1481-9.
PMID: 22037645
PMC: 4286294.
DOI: 10.1038/nm.2513.
The gp130 receptor cytokine family: regulators of adipocyte development and function.
White U, Stephens J
Curr Pharm Des. 2011; 17(4):340-6.
PMID: 21375496
PMC: 3119891.
DOI: 10.2174/138161211795164202.
Adipokines in inflammation and metabolic disease.
Ouchi N, Parker J, Lugus J, Walsh K
Nat Rev Immunol. 2011; 11(2):85-97.
PMID: 21252989
PMC: 3518031.
DOI: 10.1038/nri2921.
Type 2 diabetes as an inflammatory disease.
Donath M, Shoelson S
Nat Rev Immunol. 2011; 11(2):98-107.
PMID: 21233852
DOI: 10.1038/nri2925.
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.
Sabio G, Davis R
Trends Biochem Sci. 2010; 35(9):490-6.
PMID: 20452774
PMC: 2975251.
DOI: 10.1016/j.tibs.2010.04.004.
The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.
Paglialunga S, Fisette A, Munkonda M, Gao Y, Richard D, Cianflone K
BMC Physiol. 2010; 10:4.
PMID: 20416070
PMC: 2875207.
DOI: 10.1186/1472-6793-10-4.
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.
Mas E, Danjoux M, Garcia V, Carpentier S, Segui B, Levade T
PLoS One. 2009; 4(11):e7929.
PMID: 19936233
PMC: 2775411.
DOI: 10.1371/journal.pone.0007929.
The role of interleukins in insulin resistance and type 2 diabetes mellitus.
Feve B, Bastard J
Nat Rev Endocrinol. 2009; 5(6):305-11.
PMID: 19399017
DOI: 10.1038/nrendo.2009.62.
